Novo Nordisk A/S (NVO)

Last Closing Price: 39.78 (2026-03-09)

Weighted-Average Shares Outstanding (Diluted) (Annual)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Novo Nordisk A/S (NVO) had Weighted-Average Shares Outstanding (Diluted) of 4.45B for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$46.79B
$15.51B
$8.90B
$37.89B
$27.46B
$19.33B
$436.33M
$19.76B
$19.76B
$15.51B
$15.51B
$15.51B
$15.51B
$19.33B
$22.66B
4.44B
Weighted-Average Shares Outstanding (Diluted)
4.45B
$3.49
$3.49
Balance Sheet Financials
$26.11B
$31.55B
$56.09B
$82.20B
$32.65B
$18.01B
$20.17B
$52.82B
$29.38B
$9.69B
$29.38B
4.46B
Cash Flow Statement Financials
$18.03B
$-11.98B
$-4.30B
$2.37B
$4.01B
$1.64B
$217.26M
$-7.84B
--
Fundamental Metrics & Ratios
0.80
--
--
0.38
0.67
80.98%
41.30%
41.30%
48.42%
42.24%
33.14%
$8.93B
--
--
--
0.57
1.18
3.47
105.33
52.79%
160.07%
18.87%
32.73%
$6.58
$2.01
$4.05